Trump, who after almost every mass shooting has responded to questions on gun control with an answer about mental health, also noted the need for mental health institution reform. His plan states that "[f]amilies, without the ability to get the information needed to help those who are ailing, are too often not given the tool to help their loved ones." Beyond this statement, however, Trump gives no solution. Instead, writing that "there are promising reforms being developed in Congress that should receive bi-partisan support."
Another recent talking point that has made its way into the healthcare plan is pharmaceutical drugs, special interest control of prices, and the need to be able to negotiate. Though this talking point seemed to stem from former Bush finance chairman Woody Johnson's attendance to a GOP debate, Trump has since included the need to negotiate prices and unleash Washington from its special interest hold.
The final point in his plan states the need to "[R]emove barriers to entry into free markets for drug providers that offer safe, reliable and cheaper products."
Trump says that "Congress will need the courage to step away from the special interests and do what is right for America" and that despite pharmaceuticals being private companies, they "provide a public service." Trump instead is advocating for international competition and the importing of drugs from overseas to "bring more options to consumers."